11/21/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Cosentyx

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Sekukinumab

Sekukinumab

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Moritz MJ et al. Transplant Pregnancy Register International. 2016 Annual Report.

  2. Deshpande NA, Coscia LA, Gomez-Lobo V, Moritz MJ, Armenti VT. Pregnancy after solid organ transplantation: a guide for obstetric management. Rev Obstet Gynecol. 2013;6:116-25.

  3. Coscia LA, Constantinescu S, Moritz MJ, Frank AM, Ramirez CB, Maley WR et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation Clin Transpl. 2010;65-68.

  4. Armenti VT, Constantinescu S, Moritz MJ, Davison JM Pregnancy after transplantation. Transplantation Reviews 2008;22:223-240.

  5. Warren RB, Reich K, Langley RG, Strober B, Gladman D, Deodhar A et al. Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database. Br J Dermatol. 2018;179(5):1205-1207.

  6. Gallo L, Ruggiero A, Balato A, Megna M, Fabbrocini G. Secukinumab during pregnancy: a case report and review of literature. J Dermatolog Treat. 2020;0(0):1-2.

  7. EMA. Cosentyx. Assessment report 2014-11-20. https://goo.gl/UVVX4F

  8. FDA. Cosentyx. Clinical Pharmacology and Biopharmaceutics Review 2013-10-21. https://goo.gl/dpwFVv

  9. Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 2010;4:603-5.

  1. Moritz MJ et al. Transplant Pregnancy Register International. 2016 Annual Report.
  2. Deshpande NA, Coscia LA, Gomez-Lobo V, Moritz MJ, Armenti VT. Pregnancy after solid organ transplantation: a guide for obstetric management. Rev Obstet Gynecol. 2013;6:116-25.
  3. Coscia LA, Constantinescu S, Moritz MJ, Frank AM, Ramirez CB, Maley WR et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation Clin Transpl. 2010;65-68.
  4. Armenti VT, Constantinescu S, Moritz MJ, Davison JM Pregnancy after transplantation. Transplantation Reviews 2008;22:223-240.
  5. Warren RB, Reich K, Langley RG, Strober B, Gladman D, Deodhar A et al. Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database. Br J Dermatol. 2018;179(5):1205-1207.
  6. Gallo L, Ruggiero A, Balato A, Megna M, Fabbrocini G. Secukinumab during pregnancy: a case report and review of literature. J Dermatolog Treat. 2020;0(0):1-2.
  7. EMA. Cosentyx. Assessment report 2014-11-20. https://goo.gl/UVVX4F
  8. FDA. Cosentyx. Clinical Pharmacology and Biopharmaceutics Review 2013-10-21. https://goo.gl/dpwFVv
  9. Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 2010;4:603-5.